Work

Efficacy and safety of trabectedin in an elderly patient subgroup (≥65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) from the Expanded Access Program (EAP)

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx387.025

Authors: R.L. Jones, R. Maki, S. Patel, G. Wang, C.R. Shin, R. Knoblauch, G.D.S. Demetri

Institutions: Institute of Cancer Research, Royal Marsden Hospital, The University of Texas MD Anderson Cancer Center, Janssen Research & Development (United States), Janssen Scientific Affairs (United States), Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2760997047

FWCI: 0.226

Cites:

Cited by: 1

Related to: 10